Cholesterol, apolipoproteins, and the risk of myocardial infarction

David Crook, Ian F. Godsland, Victor Wynn, Robert S. Rosenson, Robert I. Myers, Joel A. Simon, Warren S. Browner, Stephen B. Hulley, Meir J. Stampfer, Frank M. Sacks, Simonetta Salvini, Walter C. Willett, Charles H. Hennekens

Research output: Contribution to journalLetterpeer-review

1 Scopus citations


To the Editor: Although the status of plasma high-density lipoprotein (HDL) levels as a marker of protection against cardiovascular disease is well established, the value of more detailed analyses of this class of lipoproteins is less certain. Stampfer et al. (Aug. 8 issue)1 evaluated the predictive strength of HDL subfractions in 246 men who had myocardial infarction and 246 controls. The authors concluded that measurement of the HDL subfractions (HDL2 and HDL3) was no more predictive than measurement of total HDL. This finding contrasts with those of case–control studies in which HDL2 appeared to be a. . .

Original languageEnglish
Pages (from-to)490-492
Number of pages3
JournalNew England Journal of Medicine
Issue number7
StatePublished - 13 Feb 1992
Externally publishedYes


Dive into the research topics of 'Cholesterol, apolipoproteins, and the risk of myocardial infarction'. Together they form a unique fingerprint.

Cite this